• 1
    Mumford JA, Chambers TM. Equine influenza; in Nicholson KG, Hay AJ, Webster RG (eds): Textbook of Influenza, 1st edn. Oxford: Blackwell Scientific Press, 1998; 146162.
  • 2
    Kawaoka Y, Bean WJ, Webster RG. Evolution of the hemagglutinin of equine H3 influenza viruses. Virology 1989; 169:283292.
  • 3
    Murcia PR, Wood JL, Holmes EC. Genome-scale evolution and phylodynamics of equine H3N8 influenza A virus. J Virol 2011; 85:53125322 Epub 2011/03/25.
  • 4
    Guo Y, Guo Z, Pan X, Guo C, Wang M, Liu X et al. Etiologic and seroepidemiologic surveys of equine influenza epidemic in northeast China. Chin J Exp Clin Virol 1990; 3:318323.
  • 5
    Guo Y, Wang M, Kawaoka Y, Gorman O, Ito T, Saito T et al. Characterization of a new avian-like influenza A virus from horses in China. Virology 1992; 188:245255.
  • 6
    Chambers TM, Lai ACK, Powell DG, Shortridge KF. Equine influenza in China, including Hong Kong, 1989–1994. A review; in Dodet B, Vicari M (eds): Emergence and Control of Zoonotic Ortho- and Paramyxovirus Diseases. Montrougue (France): John Libbey Eurotext, 2001; 5564.
  • 7
    Morens DM, Taubenberger JK. An avian outbreak associated with panzootic equine influenza in 1872: an early example of highly pathogenic avian influenza? Influenza Other Respi Viruses 2010; 4:373377.
  • 8
    Suzuki Y, Ito T, Suzuki T, Holland RE Jr, Chambers TM, Kiso M et al. Sialic acid species as a determinant of the host range of influenza A viruses. J Virol 2000; 74:1182511831.
  • 9
    Lin C, Holland RE Jr, Williams NM, Chambers TM. Cultures of equine respiratory epithelial cells and organ explants as tools for the study of equine influenza virus infection. Arch Virol 2001; 146:22392247.
  • 10
    Rees WA, Harkins JD, Lu M, Holland RE Jr, Lehner AF, Tobin T et al. Pharmacokinetics and therapeutic efficacy of rimantadine in horses experimentally infected with influenza virus A2. Am J Vet Res 1999; 60:888894.
  • 11
    Chambers TM, Holland RE, Tudor LR, Townsend HG, Cook A, Bogdan J et al. A new modified live equine influenza virus vaccine: phenotypic stability, restricted spread and efficacy against heterologous virus challenge. Equine Vet J 2001; 33:630636.
  • 12
    Chambers TM, Quinlivan M, Sturgill T, Cullinane A, Horohov DW, Zamarin D et al. Influenza A viruses with truncated NS1 as modified live virus vaccines: pilot studies of safety and efficacy in horses. Equine Vet J 2009; 41:8792.
  • 13
    Adams AA, Sturgill TL, Breathnach CC, Chambers TM, Siger L, Minke JM et al. Humoral and cell-mediated immune responses of old horses following influenza recombinant canarypox virus vaccination and challenge. Vet Immunol Immunopathol 2011; 139:128140.
  • 14
    Lu Z, Dubovi EJ, Zylich NC, Crawford PC, Sells S, Go YY et al. Diagnostic application of H3N8-specific equine influenza real-time reverse transcription polymerase chain reaction assays for the detection of Canine influenza virus in clinical specimens. J Vet Diagn Invest 2010; 22:942945.
  • 15
    OIE. Equine influenza; in: Manual of Diagnostic Tests and Vaccines for Terrestrial Animals, 7th edn. Paris: World Organisation for Animal Health (OIE), 2012; 865878.